Site search
2956 results for '' found
Screening for cardiac amyloidosis in patients with new conduction disease at the Alfred (ACTRN12624000520538)
Screening for cardiac amyloidosis in patients with new conduction disease at the Alfred (ACTRN12624000520538)
/
Moderately accelerated pacing in patients with cardiac amyloidosis (ACTRN12625000386437)
Moderately accelerated pacing in patients with cardiac amyloidosis (ACTRN12625000386437)
/
A Phase 2, Multicenter, Randomized, Open-label Trial to Evaluate Safety and Efficacy of Two Dose Levels of Quizartinib as Maintenance for Adult Patients with Newly Diagnosed FLT3-ITD + Acute M
A Phase 2, Multicenter, Randomized, Open-label Trial to Evaluate Safety and Efficacy of Two Dose Levels of Quizartinib as Maintenance for Adult Patients with Newly Diagnosed FLT3-ITD + Acute M
/
Alfred Mental & Addiction Health Cultural Safety, Equity and Access Strategic Direction 2026-2028 pdf
AMAH_CSEA_Strategy_Direction_2026-2028_Digital.pdf
Transition_Care_Program_Guide.pdf
Transition_Care_Program_Client_Service_Agreement.pdf
Wellness_Centre_Newsletter_May_2026.pdf
https://www.clinicaltrialsandresearch.vic.gov.au/ethics-application
https://app.prompt.org.au/download/262643?code=221a80cb-7815-492b-abd8-fe954d16edd6
https://app.prompt.org.au/download/262288?code=27ce0a0c-3eb0-4d7e-99bb-ee57ee71e004